Saffron extract (Affron)

Saffron extract (Affron)

Saffron extract is a concentrated dose of the same red threads used in cooking, standardised so the active compounds (mostly crocins and safranal) are consistent in every capsule. Affron is the most studied branded version. People take it as a gentler, non-prescription alternative when they want to lift low mood, take the edge off anxiety, sleep more soundly, or smooth out PMS or perimenopausal mood symptoms.
It sits in the same broad category as SSRIs in terms of how it behaves, but at a much milder magnitude. The realistic expectation is something between a placebo and a low-dose antidepressant: most studies show a modest but real effect on mood and stress over 4-12 weeks, with very few side effects. It's not a stimulant, not a sedative, and not something you feel in 30 minutes. The improvement creeps up over weeks.

Deep-dive

Saffron's two best-studied active compounds are crocins (water-soluble carotenoids responsible for the red colour) and safranal (the volatile compound responsible for the smell). Affron is standardised to at least 3.5% Lepticrosalides, the trademarked combined measure of crocins and safranal, which is why the data on it is more consistent than studies using raw saffron stigmas.
How it works. The mechanisms are multi-modal but converge on serotonin. Crocin and safranal inhibit serotonin reuptake in synapses, similar in principle to SSRIs but milder. Crocins also weakly inhibit monoamine oxidase A and B, the enzymes that break down serotonin, dopamine, and noradrenaline. There's also evidence saffron's metabolites protect serotonergic neurons from oxidative stress and stimulate BDNF production, which is the same neurotrophic factor that conventional antidepressants upregulate over weeks. NMDA receptor modulation, GABA-ergic effects, and HPA axis normalisation also show up in the mechanistic literature. The short version: it's not a single-target drug, it's a botanical that nudges several mood-relevant systems at once.
Mood and depression. This is the strongest evidence base. The largest trial to date, a 12-week placebo-controlled study in 202 adults with subclinical depressive symptoms, found 28 mg/day of Affron produced a statistically significant reduction in DASS-21 depression scores (Cohen's d = 0.39), with 72% of the saffron group achieving a clinically meaningful improvement vs. 54% on placebo. Effects became noticeable around week 5. A 2018 meta-analysis of 23 trials confirmed a large effect on depressive and anxiety symptoms across populations. Multiple head-to-head trials have shown saffron at 30 mg/day is roughly as effective as fluoxetine 20 mg for mild-to-moderate depression with fewer adverse events. Important caveat: most early trials were small, conducted in Iran, and used non-standardised extracts. The newer Affron trials are larger and better-controlled but most are funded by the manufacturer, which is worth knowing.
Sleep. Two RCTs in adults with poor sleep tested Affron at 14-28 mg taken an hour before bed. The first 28-day trial (14 mg twice daily) showed reduced insomnia severity and improved sleep quality. A larger follow-up in 120 adults found similar improvements at both 14 mg and 28 mg taken once before bed, with no clear advantage of the higher dose. The effect is on subjective sleep quality and ease of falling asleep, not deep sleep architecture. It doesn't sedate you, it seems to settle the nervous system enough that sleep happens more easily.
PMS, PMDD, and perimenopause. Saffron has held up well in women's mental health trials specifically. In a randomised trial of 50 women with PMS, 30 mg/day across two cycles produced a 50%+ reduction in symptoms in 76% of women on saffron vs. 8% on placebo. In a head-to-head trial against fluoxetine for PMDD, saffron 30 mg/day during the luteal phase produced comparable improvement with fewer side effects. A meta-analysis pooling these studies found a strong overall effect on PMS symptoms (SMD -0.64). For perimenopause, a 12-week trial of 86 women on Affron 28 mg/day found a 33% reduction in anxiety and 32% reduction in depression scores, but no benefit for hot flushes or other vasomotor symptoms. The takeaway: saffron is good for the psychological symptoms of hormonal transitions, not the physical ones. It's not a substitute for HRT.
SSRI-related sexual dysfunction. This is one of the more interesting niche findings. In a 4-week trial in men on fluoxetine with sexual dysfunction, 30 mg/day of saffron significantly improved erectile function. A parallel trial in women showed improvement in arousal, lubrication, and pain. So if you're on an SSRI and dealing with the sexual side effects, saffron is one of a small number of well-evidenced add-ons.
Adolescents. An 8-week trial in 80 youth aged 12-16 with mild-to-moderate anxiety or depression found Affron 14 mg twice daily reduced internalising symptoms by 33% vs. 17% on placebo. Notably, the kids reported the improvement, but their parents didn't always notice it. No adverse effects.
Eye health. A side branch of the literature. Multiple small trials have shown 20-30 mg/day improves retinal function in early age-related macular degeneration, with longer-term follow-up suggesting preservation of central retinal function over 12+ months. The evidence is interesting but smaller and less replicated than the mood data.
Limitations of the evidence. Most positive trials are short (4-12 weeks), many are small, and a meaningful proportion of the modern Affron-specific trials are funded by Pharmactive (the manufacturer). The placebo response in mood studies is consistently large, which means the absolute drug-placebo gap is modest even when statistically significant. Saffron is a real intervention with a real signal, but it's a botanical with a mild effect size, not an SSRI replacement for moderate-to-severe depression.
Women. Women have actually been better-studied with saffron than with most compounds, since several of the strongest trials are in PMS, PMDD, and perimenopause specifically. The mood effect appears similar between sexes at the same dose. No dose adjustment by sex is needed. Skip it during pregnancy and breastfeeding. Saffron at high doses has uterine-stimulating effects and there isn't enough safety data in these populations.

Dosage:

  • Standard dose: 28-30 mg/day of a standardised extract like Affron. This is the dose used in essentially every mood, sleep, and anxiety trial that has shown a positive result. More isn't better, the dose-response curve is flat above 30 mg in most studies
  • Splitting: Many trials use 14 mg twice daily (morning and evening), but once-daily dosing has worked equally well. Pick whichever fits your routine
  • For sleep specifically: 14-28 mg taken about an hour before bed. Don't bother layering it on top of other sedating compounds, it doesn't sedate, it just smooths the path to sleep
  • For PMS or PMDD: 30 mg/day across the cycle, or 30 mg/day during the luteal phase only (the two weeks before your period). Both protocols have evidence
  • For SSRI-related sexual dysfunction: 30 mg/day taken alongside the SSRI. Effects show up over 2-4 weeks
  • Timing: Doesn't matter much for absorption. Saffron is reasonably bioavailable in any form. Standardised capsules are far more reliable than cooking saffron, where the dose is impossible to control
  • Standardisation matters more than brand. Look for an extract standardised to at least 3.5% crocins and safranal (Affron's spec). Generic saffron extracts without standardisation vary wildly
  • Onset: Subjective improvement typically shows up around week 2-5. If you don't feel anything in 6-8 weeks, it's probably not going to work for you

Here's what you can expect:

The effect is subtle and gradual. In the first couple of weeks you may notice nothing. Around week 3-5, mood typically settles, daily stress feels less spiky, sleep gets a bit easier, and the low-grade anxiety that hums in the background quietens. Most people describe it as feeling more even rather than feeling better, which is exactly what an SSRI-like compound at a mild dose should do.
For sleep, the benefit shows up faster, often within the first 1-2 weeks: easier sleep onset, less mid-night wakefulness, slightly more refreshing mornings. You don't feel drowsy after taking it.
For PMS or PMDD, expect to evaluate it across at least 2 cycles. The first cycle is often partial, the second is usually where the effect lands.
If you're hoping for a dramatic mood lift or something you can feel within hours, saffron will disappoint you. The clinical effect size is real (Cohen's d around 0.4 in the largest trial, which is meaningful but modest) but it's the kind of thing you notice when you stop taking it more than when you start.

Side effects & risks:

  • Very well tolerated. Across 23 trials, saffron consistently shows fewer adverse events than SSRIs and a placebo-comparable side effect profile at clinical doses. This is one of its main practical advantages
  • Mild GI effects are the most common: nausea, reduced appetite, occasionally mild diarrhoea. Usually fades within the first week
  • Blood pressure could theoretically lower blood pressure
  • Headache and drowsiness in a small minority of users
  • SSRI/SNRI/MAOI interactions: Saffron has serotonergic activity, so combining it with prescription antidepressants is not zero-risk. That said, multiple adjunct trials have layered 30 mg/day Affron on top of SSRIs without increasing adverse events, and no published case has documented serotonin syndrome from saffron + SSRI at standard doses. With MAOIs the caution is much firmer, avoid the combination. With SSRIs and SNRIs, talk to your prescriber, but it's not a hard contraindication
  • Pregnancy: Avoid. Saffron at higher doses can stimulate uterine contractions, and there isn't enough data on lower doses during pregnancy to call it safe. Same for breastfeeding
  • Bipolar disorder: Like any compound that nudges serotonin upward, saffron has the theoretical potential to destabilise mood in bipolar disorder. If you have bipolar I or II, talk to a psychiatrist before starting
  • Allergic reactions are rare but possible, particularly in people with allergies to other Iridaceae plants
  • Toxicity: Above 5 g/day saffron is toxic, causing dizziness, vomiting, and uterine bleeding. You'd have to deliberately overdose to get there with standardised extract capsules, but it's worth knowing the upper limit exists
  • Long-term safety data is limited. Most trials run 4-12 weeks, the longest is around 26 weeks. Beyond that, human safety data thins out. Periodic breaks (e.g. 1 week off every 8-12 weeks) are sensible if you're using it long-term
Sold as a dietary supplement in most countries without prescription.